Bristol-Myers Squibb Company (BRM DU) stock market data APIs
€37.1244
-0.42(-1.1%)
as of October 17, 2025
Try our APIs with
free plan!
Bristol-Myers Squibb Company Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for BRM.DU.
Prev. Close
37.1244
Open
36.7015
High
37.2881
Low
36.6429
52 wk Range
36.6026-56.084
Market Cap
110 771 M
Dividends (Yield)
0.0155
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Bristol-Myers Squibb Company data using free add-ons & libraries
Get Bristol-Myers Squibb Company Fundamental Data
Bristol-Myers Squibb Company Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Bristol-Myers Squibb Company News
New
SystImmune, Inc. and Bristol Myers Squibb Announce First Global Phase I Results of Iza-bren, an EGFR x HER3 Bispecific Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors at ESMO 2025
REDMOND, Wash. and PRINCETON, N.J., Oct. 17, 2025 /PRNewswire/ -- SystImmune Inc. (SystImmune), a clinical-stage biotechnology company, and Bristol Myers Squibb (NYSE: BMY) today announced the oral pr...
In the Wake of Bristol Myers' $1.5B Business Acquisition, LegalMatch.com Emphasizes the Need for Expert Legal Guidance in Mergers
LegalMatch Highlight Critical Legal Considerations in Major Business Mergers and Acquisitions RENO, NEVADA / ACCESS Newswire / October 17, 2025 / Following the recent $1.5 billion acquisition of priv...
Bristol Myers Squibb Foundation Awards Grant to PATH to Improve Care for Inherited Blood Disorders in India
New initiative aims to build capacity in high-prevalence areas to increase screening and prevention of hemoglobinopathies NORTHAMPTON, MA / ACCESS Newswire / October 17, 2025 / PATH has launched a gr...
Does BMY's AI Collaboration With insitro Signal a New Growth Path in Neuroscience?
On October 14, insitro and Bristol-Myers Squibb announced an extension of their collaboration to accelerate AI-driven discovery of novel small molecule therapies for amyotrophic lateral sclerosis (ALS...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
